The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial
収録刊行物
-
- Critical Care
-
Critical Care 22 (1), 2018-03-21
Springer Science and Business Media LLC